| Naphthoquinone derivatives as scaffold to develop new drugs for tuberculosis treatment PCB Halicki, LA Ferreira, KCG De Moura, PF Carneiro, KP Del Rio, ... Frontiers in Microbiology 9, 673, 2018 | 40 | 2018 |
| Toxicity evaluation of nanocrystalline silver-impregnated coated dressing on the life cycle of worm Caenorhabditis elegans A Ayech, ME Josende, J Ventura-Lima, C Ruas, MA Gelesky, A Ale, ... Ecotoxicology and Environmental Safety 197, 110570, 2020 | 18 | 2020 |
| Design of hybrid molecules as antimycobacterial compounds: Synthesis of isoniazid-naphthoquinone derivatives and their activity against susceptible and resistant strains of … WJ Reis, ÍAO Bozzi, MF Ribeiro, PCB Halicki, LA Ferreira, PEA da Silva, ... Bioorganic & Medicinal Chemistry 27 (18), 4143-4150, 2019 | 17 | 2019 |
| Detection of Helicobacter pylori CagA EPIYA in gastric biopsy specimens and its relation to gastric diseases JS Vianna, IB Ramis, PCB Halicki, OL Gastal, RA Silva, JS Junior, ... Diagnostic microbiology and infectious disease 83 (2), 89-92, 2015 | 15 | 2015 |
| Metal‐based antimicrobial strategies against intramacrophage Mycobacterium tuberculosis TS Coelho, PCB Halicki, L Silva Jr, JR de Menezes Vicenti, BL Gonçalves, ... Letters in Applied Microbiology 71 (2), 146-153, 2020 | 14 | 2020 |
| Relationship of interleukin-1B gene promoter region polymorphism with Helicobacter pylori infection and gastritis IB Ramis, JS Vianna, PCB Halicki, C Lara, TF Tadiotto, JB da Silva Maciel, ... The Journal of Infection in Developing Countries 9 (10), 1108-1116, 2015 | 14 | 2015 |
| Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with isoniazid and rifampicin LPC Barros, KP Del Rio, TSC Carvalho, MCFR Pinto, KCG de Moura, ... Tuberculosis 111, 198-201, 2018 | 13 | 2018 |
| Antibiofilm Potential of Arenecarbaldehyde 2-Pyridinylhydrazone Derivatives Against Acinetobacter baumannii PCB Halicki, V Radin, A von Groll, MV Nora, AC Pinheiro, PEA da Silva, ... Microbial Drug Resistance 26 (12), 1429-1436, 2020 | 12 | 2020 |
| Alternative pharmaceutical formulation for oral administration of rifampicin PCB Halicki, G Hädrich, R Boschero, LA Ferreira, A von Groll, ... ASSAY and Drug Development Technologies 16 (8), 456-461, 2018 | 12 | 2018 |
| Mushroom extract of Lactarius deliciosus (L.) Sf. Gray as biopesticide: Antifungal activity and toxicological analysis LM Volcão, PCB Halicki, A Christ-Ribeiro, DF Ramos, E Badiale-Furlong, ... Journal of Toxicology and Environmental Health, Part A 85 (2), 43-55, 2022 | 10 | 2022 |
| Duroia saccifera: in vitro germination, friable calli and identification of β-sitosterol and stigmasterol from the active extract against Mycobacterium tuberculosis SA Lozano, ABB Sousa, JC Souza, DR Silva, MGM Salazar, PCB Halicki, ... Rodriguésia 71, e01092019, 2020 | 10 | 2020 |
| Chemical Profile and Antimicrobial Activity of the Marine Diatom Chaetoceros muelleri DF Ramos, PC Bartolomeu Halicki, C da Silva Canielles Caprara, ... Chemistry & Biodiversity 19 (5), e202100846, 2022 | 9 | 2022 |
| Biological activity of aqueous extracts of Southern Brazilian mushrooms LM Volcão, PB Halicki, D Bilibio, DF Ramos, E Bernardi, ... International Journal of Environmental Health Research 31 (2), 148-159, 2021 | 9 | 2021 |
| Benzo[a]phenazine derivatives: Promising scaffolds to combat resistant Mycobacterium tuberculosis PCB Halicki, EN da Silva, GAM Jardim, RG Almeida, JRM Vicenti, ... Chemical Biology & Drug Design 98 (3), 352-362, 2021 | 7 | 2021 |
| 2, 2, 2-trifluoro-1-(1, 4, 5, 6-tetrahydropyridin-3-yl) ethanone derivative as efflux pump inhibitor in Mycobacterium tuberculosis PCB Halicki, JS Vianna, N Zanatta, VP de Andrade, M de Oliveira, ... Bioorganic & Medicinal Chemistry Letters 42, 128088, 2021 | 7 | 2021 |
| Bioassays for the evaluation of reclaimed opencast coal mining areas LC Honscha, AS Campos, RA Tavella, PF Ramires, LM Volcão, ... Environmental Science and Pollution Research 28, 26664-26676, 2021 | 7 | 2021 |
| Activity of rifabutin and hemi-synthetic derivatives against Mycobacterium abscessus IB Ramis, R Figueiredo, DF Ramos, PCB Halicki, A von Groll, M Viveiros, ... Medicinal Chemistry 14 (4), 394-399, 2018 | 7 | 2018 |
| Development of lipid nanocarriers for tuberculosis treatment: Evaluation of suitable excipients and nanocarriers G Hädrich, GR Vaz, R Boschero, AS Appel, C Ramos, PCB Halicki, ... Current Drug Delivery 18 (6), 770-778, 2021 | 5 | 2021 |
| Whole-genome sequencing as a tool for studying the microevolution of drug-resistant serial Mycobacterium tuberculosis isolates JL do Carmo Guimarães, A von Groll, G Unis, ER Dalla-Costa, ... Tuberculosis 131, 102137, 2021 | 3 | 2021 |
| Synthesis, modeling and biological activity of new zinc (II) hydroxamates against Streptococcus pneumoniae BL Gonçalves, DF Ramos, PCB Halicki, PEA da Silva, ... Chemical Data Collections 22, 100240, 2019 | 3 | 2019 |
